|
Age, y (median, Q1–3)
|
64 (55, 73)
|
61 (52,72)
|
58 (49, 69))
|
<0.001
|
|
Male, n (%)
|
711(58.3)
|
501 (64.5%)
|
616 (67.7)
|
<0.001
|
|
Tobacco use, n (%)
| | | |
0.036
|
|
Never
|
712 (58.4)
|
428 (55.1)
|
480 (52.7)
| |
|
Quit
|
110 (9.0)
|
74 (9.5)
|
79 (8.7)
| |
|
Current
|
351 (28.8)
|
246 (31.7)
|
320 (35.2)
| |
|
Alcohol consumption, n (%)
| | | |
0.164
|
|
Mild
|
213 (17.5)
|
132 (17.0)
|
171 (18.8)
| |
|
Moderate to severe
|
165 (13.5)
|
131 (16.9)
|
152 (16.7)
| |
|
Never
|
817 (67.0)
|
494 (63.6)
|
564 (62.0)
| |
|
BMI, kg/m2 (median, Q1–3)
|
25.0 (22.9,27.3)
|
24.5 (22.5,26.8)
|
24.2 (22.0,26.2)
|
<0.001
|
|
NIHSS (median,Q1-Q3)
|
5 (2–9)
|
5 (2,9)
|
4 (2–8)
|
0.002
|
|
Creatinine,m mol L−1 (median, Q1–3)
|
71.2 (58.0, 87.0)
|
72.0 (60.0, 87.0)
|
71.8 (59.9, 86.7)
|
0.425
|
|
LDL, m mol L−1 (median, Q1–3)
|
3.0 (2.4, 3.6)
|
2.9 (2.3, 3.5)
|
2.8 (2.3, 3.4)
|
0.001
|
|
HDL,m mol L−1(median, Q1–3)
|
1.1(1.0, 1.3)
|
1.2 (1.0, 1.4)
|
1.2 (1.1, 1.4)
|
<0.001
|
|
Systolic blood pressure, mmHg (median, Q1–3)
|
150 (138, 160)
|
143 (130, 160)
|
146 (130, 160)
|
<0.001
|
|
Homocysteine, μ mol L−1, (median, Q1–3)
|
14.4 (11.5, 18.7)
|
15.5 (12.0, 21.9)
|
15.7 (12.3, 22.8)
|
<0.001
|
|
HOMA2-IR (median, Q1–3)
|
2.5 (1.6, 4.0)
|
1.9 (1.1, 3.0)
|
1.6 (0.9, 2.5)
|
<0.001
|
|
Past medical history, yes, n (%)
| | | | |
|
Coronary artery disease
|
172 (14.1)
|
87 (11.2)
|
90 (9.9)
|
0.009
|
|
Hypertension
|
795 (65.2)
|
470 (60.5)
|
514 (56.5)
|
<0.001
|
|
Atrial fibrillation
|
66 (5.4)
|
54 (6.9)
|
31 (3.4)
|
0.006
|
|
Stroke types, n (%)
| | | |
<0.001
|
|
IS
|
1015 (83.2)
|
541 (69.6)
|
675 (74.2)
| |
|
ICH
|
174 (14.3)
|
185 (23.8)
|
198 (21.8)
| |
|
SAH
|
31 (2.5)
|
51 (6.6)
|
37 (4.1)
| |
